The DOI matches its Crossref record; 56 of the 60 references it cites were found in a registry or an index.
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial
Open accessAbstract
Background Treatment-resistant major depression is common and potentially life-threatening in elderly people, in whom little is known about the benefits and risks of augmentation pharmacotherapy. We aimed to assess whether aripiprazole is associated with a higher probability of remission than is placebo.Methods We did a randomised, double-blind, placebo-controlled trial at three centres in the USA and Canada to test the efficacy and safety of aripiprazole augmentation for adults aged older than 60 years with treatment-resistant depression (Montgomery Asberg Depression Rating Scale [MADRS] score of ≥15). Patients who did not achieve remission during a pre-trial with venlafaxine extended-release (150-300 mg/day) were randomly assigned (1:1) to the addition of aripiprazole (target dose 10 mg [maximum 15 mg] daily) daily or placebo for 12 weeks. The computer-generated randomisation was done in blocks and stratified by site. Only the database administrator and research pharmacists had knowledge of treatment assignment. The primary endpoint was remission, defined as an MADRS score of 10 or less (and at least 2 points below the score at the start of the randomised phase) at both of the final two consecutive visits, analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00892047.Findings From July 20, 2009, to Dec 30, 2013, we recruited 468 eligible participants, 181 (39%) of whom did not remit and were randomly assigned to aripiprazole (n=91) or placebo (n=90). A greater proportion of participants in the aripiprazole group achieved remission than did those in the placebo group (40 [44%] vs 26 [29%] participants; odds ratio [OR] 2·0 [95% CI 1·1-3·7], p=0·03; number needed to treat [NNT] 6·6 [95% CI 3·5-81·8]). Akathisia was the most common adverse effect of aripiprazole (reported in 24 [26%] of 91 participants on aripiprazole vs 11 [12%] of 90 on placebo). Compared with placebo, aripiprazole was also associated with more Parkinsonism (15 [17%] of 86 vs two [2%] of 81 participants), but not with treatment-emergent suicidal ideation (13 [21%] of 61 vs 19 [29%] of 65 participants) or other measured safety variables.Interpretation In adults aged 60 years or older who do not achieve remission from depression with a first-line antidepressant, the addition of aripiprazole is effective in achieving and sustaining remission. Tolerability concerns include the potential for akathisia and Parkinsonism.Funding National Institute of Mental Health, UPMC Endowment in Geriatric Psychiatry, Taylor Family Institute for Innovative Psychiatric Research, National Center for Advancing Translational Sciences, and the Campbell Family Mental Health Research Institute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This remission rate is comparable with those seen in our previous bilateral rTMS trial (33%)7 and deep rTMS trial (40%)32 and comparable with the remission rate seen with aripiprazole augmentation in older adults with TRD.33”
In the citing paper
“The largest published randomized controlled trial to date amongst older adults (“IRL GREY”) – a multi‐site, double‐blind, placebo‐controlled trial of aripiprazole augmentation of primary pharmacotherapy with venlafaxine – demonstrated efficacy for augmentation, yielding a 44% remission rate versus 29% with placebo (number needed to treat: 6.6) 222 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [222]
In the citing paper
“Aripiprazole was well tolerated in analyses of both cardiometabolic and neurological outcomes, and led to a reduction in the prevalence and severity of suicidal ideation.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [222]
In the citing paper
“Augmentation of antidepressants with either lithium131 or with the aripiprazole132 have been found effective in late-life major depression unresponsive to an antidepressant.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Assessment of suicidal intention: The Scale for Suicide Ideation.
Beck, A. T., Kovacs, M., & Weissman, A. (1979) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.47.2.343 · Cited by 3,419
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990
Self-citationLingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
(2018) · Sage eBooks · doi:10.4135/9781506326139.n404 · Cited by 1,538
Cited by
Sorted by citations
Items 101–200 of 283
Cattarinussi, G., Moghaddam, H. S., Aarabi, M. H., Squarcina, L., Sambataro, F., Brambilla, P., & Delvecchio, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315379 · Cited by 16
Martino, D., Karnik, V., Bhidayasiri, R., Hall, D. A., Hauser, R. A., Macerollo, A., Pringsheim, T. M., Truong, D. D., Factor, S. A., Škorvánek, M., et al. (2023) · Movement Disorders · doi:10.1002/mds.29392 · Cited by 15
The effects of white matter disease on the accuracy of automated segmentation
Karim, H. T., Andreescu, C., MacCloud, R. L., Butters, M. A., Reynolds, C. F., Aizenstein, H. J., & Tudorascu, D. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.05.003 · Cited by 15
Self-citationLepola, U., Hefting, N., Zhang, D., & Hobart, M. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4952 · Cited by 15
Intervention Research in Late-Life Depression: Challenges and Opportunities
Lavretsky, H. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.10.011 · Cited by 15
Treatment selection using prototyping in latent-space with application to depression treatment
Kleinerman, A., Rosenfeld, A., Benrimoh, D. A., Fratila, R., Armstrong, C., Mehltretter, J., Shneider, E., Yaniv‐Rosenfeld, A., Karp, J. F., Reynolds, C. F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258400 · Cited by 14
Self-citationTargeting Slow Wave Sleep Deficiency in Late-Life Depression: A Case Series With Propofol
Rios, R. L., Kafashan, M., Hyche, O., Lenard, E. M., Lucey, B. P., Lenze, E. J., & Palanca, B. J. A. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.03.009 · Cited by 14
Self-citationAn inverse relationship between cortical plasticity and cognitive inhibition in late-life depression
Lissemore, J. I., Shanks, H. R. C., Butters, M. A., Bhandari, A., Zomorrodi, R., Rajji, T. K., Karp, J. F., Reynolds, C. F., Lenze, E. J., Daskalakis, Z. J., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0413-9 · Cited by 14
Self-citationBehlke, L. M., Lenze, E. J., Pham, V., Miller, J. P., Smith, T. W., Saade, Y., Karp, J. F., Reynolds, C. F., Blumberger, D. M., Stefan, C., et al. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001287 · Cited by 16
Self-citationTherapy Strategies for Late-life Depression: A Review
Piel, C., & Quante, A. (2023) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000678 · Cited by 15
Depression remission rates among older black and white adults: Analyses from the IRL-GREY trial
Hall, C. A., Simon, K. M., Lenze, E., Dew, M., Begley, A., Butters, M., Blumberger, D., Stack, J., Mulsant, B., & Reynolds, C. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400480 · Cited by 14
Self-citationMen, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Reynolds, C. F., Stefan, C., Mulsant, B. H., et al. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3162 · Cited by 13
Self-citationKim, H. K., Blumberger, D. M., Karp, J. F., Lenze, E. J., Reynolds, C. F., & Mulsant, B. H. (2022) · Evidence-Based Mental Health · doi:10.1136/ebmental-2022-300479 · Cited by 13
Self-citationAge or age of onset: which is the best criterion to classify late-life depression?
Olgiati, P., Fanelli, G., & Serretti, A. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000472 · Cited by 13
Vanderschelden, B., Gebara, M. A., Oughli, H. A., Butters, M. A., Brown, P. J., Farber, N. B., Flint, A. J., Karp, J. F., Lavretsky, H., Mulsant, B. H., et al. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5964 · Cited by 14
Self-citationHypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults
Wathra, R. A., Mulsant, B. H., Thomson, L., Goldberger, K. W., Lenze, E. J., Karp, J. F., Sanches, M., Reynolds, C. F., & Blumberger, D. M. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944154 · Cited by 15
Self-citationLee, H. H., Blumberger, D. M., Lenze, E. J., Anderson, S. J., Barch, D. M., Black, K. J., Cristancho, P., Daskalakis, Z. J., Eisenstein, S. A., Huang, Y., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.09.003 · Cited by 15
Self-citation“What else can we do?”—Provider perspectives on treatment‐resistant depression in late life
Hamm, M., Karp, J. F., Lenard, E. M., Dawdani, A., Lavretsky, H., Lenze, E. J., Mulsant, B. H., Reynolds, C. F., Roose, S. P., & Brown, P. J. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17592 · Cited by 13
Self-citationYao, Z., & McCall, W. V. (2023) · Pharmaceutical Medicine · doi:10.1007/s40290-023-00467-x · Cited by 12
Hsu, J. H., Mulsant, B. H., Lenze, E. J., Karp, J. F., Lavretsky, H., Roose, S. P., Reynolds, C. F., & Blumberger, D. M. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.04.015 · Cited by 12
Self-citationLarsen, A. J., Teobaldi, G., Jeraldo, R. I. E., Falkai, P., & Cooper, C. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2024-301324 · Cited by 13
Jeuring, H. W., d’Angremont, E., Tol, M. H., Risselada, A., Sommer, I. E., & Voshaar, R. C. O. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.115010 · Cited by 11
Sex differences in plasma proteomic markers in late-life depression
Xue, X., Demirci, D. A., Lenze, E. J., Reynolds, C. F., Mulsant, B. H., Wetherell, J. L., Wu, G. F., Blumberger, D. M., Karp, J. F., Butters, M. A., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115773 · Cited by 11
Self-citationWong, S. M. Y., Leung, D. K. Y., Liu, T., Ng, Z. L. Y., Wong, G. H. Y., Chan, W. C., & Lum, T. Y. S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06281-2 · Cited by 13
Moyano, B. P., Orgeta, V., von Gunten, A., Vandel, P., Ma, R., Stewart, R. J., & Mueller, C. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.169 · Cited by 10
Anti-Suicidal Effects of Lithium, Ketamine, and Clozapine—A 10-Year Systematic Review
Waszak, P. M., Opalko, J., Olszańska, N., & Zagożdżon, P. (2025) · Pharmaceuticals · doi:10.3390/ph18050742 · Cited by 15
Hamilton scale and MADRS are interchangeable in meta-analyses but can disagree at trial level
Guizzaro, L., Morgan, D. D. V., Falco, A., & Gallo, C. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.04.022 · Cited by 10
Dhami, P., Quilty, L. C., Schwartzmann, B., Uher, R., Allen, T. A., Kloiber, S. M., Lam, R. W. M., MacQUEEN, G. M., Frey, B. N., Milev, R. V., et al. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.12.012 · Cited by 10
Atypical antipsychotics as add-on treatment in late-life depression
Çakır, S., & Şenkal, Z. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s114244 · Cited by 10
Gebara, M. A., Kasckow, J., Smagula, S. F., DiNapoli, E. A., Karp, J. F., Lenze, E. J., Mulsant, B. H., & Reynolds, C. F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.10.013 · Cited by 10
Self-citationBousman, C., Oomen, A., Jessel, C. D., Tampi, R. R., Forester, B. P., Eyre, H. A., Lavretsky, H., & Müller, D. J. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.09.013 · Cited by 10
Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports
Arandjelovic, K., Eyre, H. A., & Lavretsky, H. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.05.010 · Cited by 10
Altmann, H. M., Kazan, J., Gebara, M. A., Blumberger, D. M., Karp, J. F., Lenze, E. J., Mulsant, B. H., Reynolds, C. F., & Stahl, S. T. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.03.002 · Cited by 10
Self-citationChen, H., Lin, Y., Zhao, Z., Lin, T., Lin, Q., Chen, X., Wu, W., Zeng, G., Wu, S., Liu, N., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14650 · Cited by 8
Management of late-life depression: a major leap forward
Thomas, A. J., & O'Brien, J. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00304-9 · Cited by 9
Jurek, L., Dorey, J., Nourredine, M., Galvão, F., & Brunelin, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.025 · Cited by 9
Rahman, T., Patrick, C. N. R., Ma, C. X., Nicol, G. E., Reynolds, C. F., Mulsant, B. H., Hartz, S. M., Yingling, M. D., & Lenze, E. J. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001335 · Cited by 9
Self-citationEspinola, C. W., Khoo, Y., Parmar, R., Demchenko, I., Frey, B. N., Milev, R. V., Ravindran, A. V., Parikh, S. V., Ho, K. T., Rotzinger, S., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2555 · Cited by 7
Clinical profiles of late-onset psychiatric patients exhibiting incidental REM sleep without atonia
Fujishiro, H., Okuda, M., Iwamoto, K., Miyata, S., Torii, Y., Iritani, S., & Ozaki, N. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02035-7 · Cited by 9
Pediatric suicide: Review of a preventable tragedy
Greydanus, D. E., Nazeer, A., Qayyum, Z., Patel, D. R., Rausch, R., Hoang, L.-N., Miller, C., Chahin, S. S., Apple, R. W., Saha, G. K., et al. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101725 · Cited by 10
Ji, M., Feng, J., & Liu, G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299020 · Cited by 8
RetractedResearch status and global trends of late-life depression from 2004 to 2023: bibliometric analysis
Du, R., Yang, K., Li, W., Wang, Z., & Cai, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1393110 · Cited by 10
Ainsworth, N. J., Oughli, H. A., Lavretsky, H., Blumberger, D. M., Brown, P. J., Butters, M. A., Karp, J. F., Lenard, E. M., Lenze, E. J., McAndrews, M. P., et al. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.09.018 · Cited by 11
Self-citationKumbhar, S. A., Kokare, C., Shrivastava, B., & Choudhury, H. (2019) · Current Nanomedicine · doi:10.2174/2468187309666190823155215 · Cited by 8
Dean, N. J., Arnaoutoglou, N. A., & Underwood, B. R. (2020) · BJPsych Open · doi:10.1192/bjo.2020.14 · Cited by 8
Shin, C., Pae, C., Kwak, K. P., Jeon, S. W., Jeong, H., Kim, J.-W., Lee, Y. J., Patkar, A. A., & Han, C. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.2.243 · Cited by 8
Hsu, J. H., Mulsant, B. H., Lenze, E. J., Sanches, M., Karp, J. F., Reynolds, C. F., & Blumberger, D. M. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11764 · Cited by 8
Self-citationTreatment-Resistant Depression
Cusin, C., & Peyda, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-97241-1_1 · Cited by 8
Adjunctive Antipsychotics in Major Depressive Disorder
McIntyre, R. S., Stahl, S. M., Shim, S. R., Pompili, M., Goldberg, J. F., Correll, C. U., Kwan, A. T. H., Dri, C. E., Xu, H., Vinberg, M., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.0658 · Cited by 10
Ainsworth, N. J., Brender, R., Gotlieb, N., Zhao, H., Blumberger, D. M., Karp, J. F., Lenze, E. J., Nicol, G. E., Reynolds, C. F., Wang, W., et al. (2023) · International Psychogeriatrics · doi:10.1017/s1041610222000862 · Cited by 8
Self-citationElsheikh, S. S. M., Marshe, V. S., Men, X., Islam, F., Gonçalves, V. F., Paré, G., Felsky, D., Kennedy, J. L., Mulsant, B. H., Reynolds, C. F., et al. (2024) · The Pharmacogenomics Journal · doi:10.1038/s41397-024-00351-0 · Cited by 7
Self-citationLissemore, J. I., Mulsant, B. H., Bonner, A. J., Butters, M. A., Chen, R. E., Downar, J. H., Karp, J. F., Lenze, E. J., Rajji, T. K., Reynolds, C. F., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.07.005 · Cited by 8
Self-citationGebara, M. A., DiNapoli, E. A., Kasckow, J., Karp, J. F., Blumberger, D. M., Lenze, E. J., Mulsant, B. H., & Reynolds, C. F. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4813 · Cited by 7
Self-citationJin, X., Xu, N., Wang, X., Songfan, L. I., Yu, Q., Liang, M., Nan, F., Shu, S., Yan, R., Zhu, Y., et al. (2021) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.954 · Cited by 7
Treatment-Resistant Depression in the Elderly: Diagnostic and Treatment Approaches
Newman, B. M. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0186-5 · Cited by 9
Oughli, H. A., Lenze, E. J., Locke, A. E., Yingling, M. D., Zhong, Y., Miller, J. P., Reynolds, C. F., Mulsant, B. H., Newcomer, J. W., Peterson, T. R., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.017 · Cited by 8
Self-citationTreatment strategy for late‐life depression
Baba, H. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.91 · Cited by 6
Jeste, D. V., Peschin, S., Buckwalter, K. C., Blazer, D. G., McGuire, M. H., Moutier, C. Y., Doederlein, A., Niederehe, G., Altman, B. A., Borenstein, J. E., et al. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.03.011 · Cited by 7
Self-citationSevere parkinsonism caused by brexpiprazole: A case report
Jackowiak, E. M., & Chou, K. L. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.013 · Cited by 6
Treatment Emergent Suicidal Ideation in depressed older adults
Cristancho, P., O'Connor, B., Lenze, E. J., Blumberger, D. M., Reynolds, C. F., Dixon, D. J., & Mulsant, B. H. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4498 · Cited by 7
Self-citationUwai, Y., & Nabekura, T. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.07.005 · Cited by 5
Wathra, R. A., Men, X., Elsheikh, S. S. M., Marshe, V. S., Rajji, T. K., Lissemore, J. I., Mulsant, B. H., Karp, J. F., Reynolds, C. F., Lenze, E. J., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02532-0 · Cited by 5
Self-citationDifferential Placebo Responses for Pharmacotherapy and Neurostimulation in Late-Life Depression
Wathra, R. A., Mulsant, B. H., Reynolds, C. F., Lenze, E. J., Karp, J. F., Daskalakis, Z. J., & Blumberger, D. M. (2022) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2021.10.019 · Cited by 5
Self-citationL’utilisation des antidépresseurs dans l’épisode dépressif caractérisé unipolaire du sujet âgé
Péricaud, A., Straczek, C., Montastruc, F., Leboyer, M., Yrondi, A., & Arbus, C. (2022) · L Encéphale · doi:10.1016/j.encep.2021.11.006 · Cited by 6
Vidya, K. L., Srivastava, S., Singh, B., & Kar, S. K. (2022) · CNS Spectrums · doi:10.1017/s1092852922001018 · Cited by 4
Jang, S.-H., Bahk, W., Woo, Y. S., Seo, J. S., Park, Y., Kim, W. K., Jeong, J., Shim, S.-H., Lee, J. G., Jon, D., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031146 · Cited by 6
Vidya, K. L., Srivastava, S., Singh, B. P., & Kar, S. K. (2023) · CNS Spectrums · doi:10.1017/s1092852923002407 · Cited by 5
A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult
Blaszczyk, A. T., Mathys, M. L., & Le, J. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01051-3 · Cited by 9
Uwai, Y., & Nabekura, T. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114687 · Cited by 5
Horoșan, L., Nistor, D.-E., Ion, A., Corban, M., & Giurgiuca, A. (2024) · Discoveries · doi:10.15190/d.2024.2 · Cited by 5
„Lithium in der Behandlung der Altersdepression. Was spricht dafür, was dagegen?“
Stühler, S., & Quante, A. (2018) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0644-2578 · Cited by 5
D’Onofrio, A. M., Ferrajoli, G. F., Balzoni, L. M., Massetti, M., Zanzarri, A., Marano, G., Mazza, M., Koukopoulos, A. E., Kotzalidis, G. D., Moccia, L., et al. (2026) · Geriatrics · doi:10.3390/geriatrics11010013 · Cited by 4
Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study
DiBello, J. R., Xiong, X., Liu, X., Zhong, W., Merola, A., Li, M., & Lu, K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06518-8 · Cited by 4
Li, Y., Lin, D., Gong, X., Fu, D., Zhao, L., Chen, W., Chen, J., Liu, S., Yang, G., & Cai, Z. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1495284 · Cited by 4
Iwamoto, K., Fujishiro, H., & Ozaki, N. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12479 · Cited by 4
Harigane, K., Mochida, Y., Shimazaki, T., Kobayashi, N., & Inaba, Y. (2022) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-022-00347-2 · Cited by 4
Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report
Torrico, T. J., Kiai, N., Meza, C., Salam, M. T., & Abdijadid, S. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01514-x · Cited by 4
Lavretsky, H., & Roose, S. P. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.10.009 · Cited by 4
Lenze, E. J., Karp, J. F., Gebara, M. A., Nicol, G. E., & Mulsant, B. H. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02338-w · Cited by 3
Self-citationAnderson, S. (2019) · Springer eBooks · doi:10.1007/978-981-10-5251-4_70 · Cited by 3
Self-citationAkgoz, I., Kara, H., Özçelik, Ö., Dönmez, L., Eryilmaz, M., & Özbey, G. (2024) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000797 · Cited by 3
Ciocotișan, I.-M., Muntean, D. M., & Vlase, L. (2024) · Metabolites · doi:10.3390/metabo14110588 · Cited by 3
Nelson, J. C. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15091220 · Cited by 3
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression
Lenze, E. J. (2023) · New England Journal of Medicine · doi:10.1056/nejmc2304804 · Cited by 3
Self-citationAn Update on Somatic Treatments for Suicide Risk
Rizk, M., & Mann, J. J. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260287 · Cited by 2
Cariprazine for late-life psychiatric illness
Mukku, S. S. R., Nadella, R. K., & Kornapalli, S. E. (2021) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_43_21 · Cited by 2
Fußer, F., Karakaya, T., & Pantel, J. (2017) · doi:10.1093/med/9780198746638.003.0017 · Cited by 2
Nakamura, T., Kuraishi, Y., Ohya, D., Kimura, K., Sasayama, D., & Washizuka, S. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12463 · Cited by 2
Karp, J. F., Brinton, R. D., Fournier, J. C. J., Harding, L., Jha, M. K., Lenze, E. J., Mathew, S. J., Meltzer-Brody, S. E., Mohr, D. C., Riva‐Posse, P., et al. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.psprmdd2408ah · Cited by 3
Self-citationCall to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults
Amodeo, K., Schneider, R. B., & Richard, I. H. (2016) · Geriatrics · doi:10.3390/geriatrics1040033 · Cited by 2
Biomarkers of cognitive impairment in late-life depression
Diniz, B. S., & Butters, M. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00007-7 · Cited by 3
Self-citationTreatment Approach and Modalities for Management of Depression in Older People
Marvanová, M., & McGrane, I. R. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.11 · Cited by 2
Psychosocial Interventions in Dementia
Kiridoshi, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.019 · Cited by 2
Review of Treatment for Late-Life Depression
Hay, K., Stageman, W., & Allan, C. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.021 · Cited by 2
Anderson, S. (2018) · Springer eBooks · doi:10.1007/978-981-10-2779-6_70-1 · Cited by 2
Self-citationAga, V. M., Shad, M. U., Zhu, H., & Salzman, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00023-5 · Cited by 2
Thoughtful prescribing for patients with difficult-to-treat depression
Soubolsky, A., Visentin, J. D., & Crawley, A. (2023) · Canadian Family Physician · doi:10.46747/cfp.6911777 · Cited by 2
Hipomania induzida por aripiprazol em uma paciente com depressão resistente ao tratamento
Monteiro, D. C., de Oliveira, J. C., Medrado, T. D. S. S., Cardoso, V. C. G., & Régis, V. G. V. D. A. (2024) · Debates em Psiquiatria · doi:10.25118/2763-9037.2024.v14.1340 · Cited by 1
Effect of Vitamin B12 supplementation in late-life depression: A randomized controlled trial
Misal, P., Srivastava, S., Sonal, A., Agarwal, V., & Ali, W. (2024) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_11_24 · Cited by 3
Aripiprazole-Associated Rhabdomyolysis
Ren, J., Nie, J., Liu, L., Sun, L., Wang, T., & Wu, J. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002031 · Cited by 1
Metadata
- Authors
- Lenze, E. J., Mulsant, B. H., Blumberger, D. M., Karp, J. F., Newcomer, J. W., Anderson, S. J., Dew, M. A., Butters, M. A., Stack, J. A., Begley, A. E., & Reynolds, C. F.
- Affiliations
- Washington University in St. Louis (US)
- Centre for Addiction and Mental Health (CA)
- University of Pittsburgh (US)
- Florida Atlantic University (US)
- Corresponding author
- Lenze, Eric J
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 386
- Issue
- 10011
- Pages
- 2404-2412
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4690746
- OpenAlex
- W1780931260
- Cited by
- 283
- References
- 60
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 25 · 2023: 28 · 2022: 26 · 2021: 25 · 2020: 50 · 2019: 26 · 2018: 21 · 2017: 21 · 2016: 23 · 2015: 6
- FWCI
- 16.92
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (P30 MH90333, R01 MH083660)
- National Heart, Lung, and Blood Institute
- Roche
- Centre for Addiction and Mental Health
- Brain and Behavior Research Foundation
- National Center for Complementary and Integrative Health
- American Foundation for Suicide Prevention
- Centre for Addiction and Mental Health Foundation
- National Center on Minority Health and Health Disparities
- National Institutes of Health
- H. Lundbeck A/S
- National Palliative Care Research Center
- Fondation Brain Canada
- John A. Hartford Foundation
- Commonwealth of Pennsylvania
- National Institute on Aging
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, geriatric depression, elderly patients, antidepressant augmentation, venlafaxine, akathisia, antipsychotic adverse effects, remission, tolerability, number needed to treat, number needed to harm, adverse drug reactions, anticholinergic effects
- MeSH terms
- Aripiprazole, Aged, Antidepressive Agents, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Parkinson Disease, Secondary, Recurrence, Treatment Outcome, Akathisia, Drug-Induced, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
